91 related articles for article (PubMed ID: 25534488)
1. Effect of Mechanism of Action of Different ω-6/ω-3 Polyunsaturated Fatty Acids Ratio on the Growth of Endometrial Carcinoma Mice.
Lu X; Ding X; Jing L
Cell Biochem Biophys; 2015 Apr; 71(3):1671-6. PubMed ID: 25534488
[TBL] [Abstract][Full Text] [Related]
2. Effects of polyunsaturated fatty acids on endometrial carcinoma Ishikawa cells.
Lu XY; Zeng T
Eur Rev Med Pharmacol Sci; 2014; 18(21):3311-4. PubMed ID: 25487944
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endometrial cancer by n-3 polyunsaturated fatty acids in preclinical models.
Zheng H; Tang H; Liu M; He M; Lai P; Dong H; Lin J; Jia C; Zhong M; Dai Y; Bai X; Wang L
Cancer Prev Res (Phila); 2014 Aug; 7(8):824-34. PubMed ID: 24866178
[TBL] [Abstract][Full Text] [Related]
4. Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production.
Pan J; Cheng L; Bi X; Zhang X; Liu S; Bai X; Li F; Zhao AZ
Sci Rep; 2015 Oct; 5():14958. PubMed ID: 26468779
[TBL] [Abstract][Full Text] [Related]
5. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
Kobayashi N; Barnard RJ; Henning SM; Elashoff D; Reddy ST; Cohen P; Leung P; Hong-Gonzalez J; Freedland SJ; Said J; Gui D; Seeram NP; Popoviciu LM; Bagga D; Heber D; Glaspy JA; Aronson WJ
Clin Cancer Res; 2006 Aug; 12(15):4662-70. PubMed ID: 16899616
[TBL] [Abstract][Full Text] [Related]
6. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.
Bradford LS; Rauh-Hain A; Clark RM; Groeneweg JW; Zhang L; Borger D; Zukerberg LR; Growdon WB; Foster R; Rueda BR
Gynecol Oncol; 2014 May; 133(2):346-52. PubMed ID: 24561032
[TBL] [Abstract][Full Text] [Related]
7. Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation.
Liu M; Zhou L; Zhang B; He M; Dong X; Lin X; Jia C; Bai X; Dai Y; Su Y; Zou Z; Zheng H
Oncotarget; 2016 Nov; 7(47):76944-76954. PubMed ID: 27769066
[TBL] [Abstract][Full Text] [Related]
8. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
Du Y; Wang L; Chen S; Liu Y; Zhao Y
Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433
[TBL] [Abstract][Full Text] [Related]
9. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer.
Apte SA; Cavazos DA; Whelan KA; Degraffenried LA
Nutr Cancer; 2013; 65(4):556-62. PubMed ID: 23659447
[TBL] [Abstract][Full Text] [Related]
10. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
[TBL] [Abstract][Full Text] [Related]
11. Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice.
Zhang Y; Xu F; Liang H; Cai M; Wen X; Li X; Weng J
Oncol Rep; 2016 Mar; 35(3):1340-8. PubMed ID: 26648451
[TBL] [Abstract][Full Text] [Related]
12. Expression of phosphorylated Akt, mTOR and MAPK in type I endometrial carcinoma: clinical significance.
Kourea HP; Nikolaou M; Tzelepi V; Adonakis G; Kardamakis D; Tsapanos V; Scopa CD; Kalofonos C; Decavalas G
Anticancer Res; 2015 Apr; 35(4):2321-31. PubMed ID: 25862896
[TBL] [Abstract][Full Text] [Related]
13. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression.
Chen Z; Zhang Y; Jia C; Wang Y; Lai P; Zhou X; Wang Y; Song Q; Lin J; Ren Z; Gao Q; Zhao Z; Zheng H; Wan Z; Gao T; Zhao A; Dai Y; Bai X
Oncogene; 2014 Sep; 33(37):4548-57. PubMed ID: 24096482
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
15. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells.
Shin SY; Lee KS; Choi YK; Lim HJ; Lee HG; Lim Y; Lee YH
Carcinogenesis; 2013 Sep; 34(9):2080-9. PubMed ID: 23689352
[TBL] [Abstract][Full Text] [Related]
16. Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in vitro and reduce glioma tumor growth in U87MG xenograft mouse model.
Jeong JC; Kim JW; Kwon CH; Kim TH; Kim YK
Phytother Res; 2011 Mar; 25(3):429-34. PubMed ID: 20737659
[TBL] [Abstract][Full Text] [Related]
17. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
[TBL] [Abstract][Full Text] [Related]
18. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
19. Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability.
Thoury A; Descatoire V; Kotelevets L; Kannengiesser C; Bertrand G; Theou-Anton N; Frey C; Genestie C; Raymond E; Chastre E; Lehy T; Walker F
Histol Histopathol; 2014 Nov; 29(11):1455-66. PubMed ID: 24811063
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
